Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.738788
Abstract: Primary membranous nephropathy (pMN) is an autoimmune kidney disease and a common cause of nephrotic syndrome in adults. Rituximab is becoming a first line therapy for patients with persistent nephrotic syndrome with proven safety and… read more here.
Keywords: rituximab; levels month; membranous nephropathy; rituximab levels ... See more keywords